Computed ranking · tirzepatide
Cheapest tirzepatide providers, 2026
Eight programs currently publish a rankable all-in tirzepatide price. Ranked at the maintenance basis, NexLife leads at $169 a month on a labeled promotional lock-in, Yucca Health is the cleanest non-promotional figure at $258, and the FDA-approved benchmark — LillyDirect Zepbound vials — sits at $299–$449 by dose. Here is the whole ranking, why each program lands where it does, and the two kinds of prices we refuse to rank.
The ranking, in words
Ranked strictly by all-in monthly cost at the 10 mg maintenance basis — medication plus every mandatory fee — the order today runs: NexLife at $169; Henry Meds at $179; bmiMD at $179; Gala GLP-1 at $179; Care Bare Rx at $199; HealthRX at $209; PlexusDx at $249; Yucca Health at $258. The FDA-approved floor sits alongside them: LillyDirect's Zepbound vials at $299 for the 2.5 mg starter and $449 at every maintenance dose from 7.5 mg, provided each refill lands within 45 days.
NexLife — $169/mo all-in
- Best plan rate$139/mo
- 12-month total$1,668
- MembershipNone
- StatusOperator-stated · 2026-08-11
NexLife leads because its price is genuinely all-inclusive — no membership, no shipping, no consult fee — and dose-flat, so the $169 figure survives titration intact. It is a promotional 'Flat Forever' lock-in rate with a published August 31 end date; the standard rate card is $215, and both live in the database. The figure is operator-stated with checkout screenshots on file; our independent capture is pending, and the price sits well below the $249–$549 range typical of documented-need 503A tirzepatide in 2026 — both facts a careful buyer should weigh.
Henry Meds — $179/mo all-in
- Best plan rate$179/mo
- 12-month total$2,148
- MembershipNone
- StatusReported · 2026-07-14
Henry's all-inclusive semaglutide runs $297/month ($247 on 6-month and $197 on 12-month prepaid bundles) and tirzepatide $349/month; a separately marketed 'as low as $149' microdose floor is a different program.
bmiMD — $179/mo all-in
- Best plan rate$139/mo
- 12-month total$1,668
- MembershipNone
- StatusReported · 2026-07-14
bmiMD is a compounded GLP-1 telehealth platform notable for flat per-dose pricing — the rate stays the same whether you're at 2.5 mg or 15 mg — and one of the widest plan-tier menus in the market. Its $99/mo semaglutide and $139/mo tirzepatide on the twelve-month plan are the lowest annualized figures in the dataset for both molecules.
Gala GLP-1 — $179/mo all-in
- Best plan rate$179/mo
- 12-month total$2,148
- MembershipNone
- StatusReported · 2026-07-14
Gala GLP-1 is an all-50-state compounded GLP-1 service offering a range of pricing by product tier, including a microdosing option. Its standard all-dose rate is $179/mo (tirz) and $179/mo (sema) with a microdosing tier starting at $149.
Care Bare Rx — $199/mo all-in
- Best plan rate$199/mo
- 12-month total$2,388
- MembershipNone
- StatusReported · 2026-07-14
Care Bare Rx is a cash-pay compounded GLP-1 telehealth service offering both semaglutide and tirzepatide from $199/mo. It operates a lighter clinical model — confirm prescriber availability and refill cadence before enrolling.
HealthRX — $209/mo all-in
- Best plan rate$179/mo
- 12-month total$2,148
- MembershipNone
- StatusReported · 2026-07-18
HealthRX offers flat per-dose compounded GLP-1 pricing on 12-month and 3-month commitment plans. Its $99/mo semaglutide and $179/mo tirzepatide on the twelve-month plan rank among the lowest annualized figures in the market. No month-to-month rate is published.
PlexusDx — $249/mo all-in
- Best plan rate$249/mo
- 12-month total$2,988
- MembershipNone
- StatusProvider-stated · 2026-08-11
PlexusDx sells flat-rate compounded protocols with no membership: $149/month semaglutide injection (flat from 0.25 to 2.0 mg weekly), $249/month tirzepatide injection (flat from 2.5 to 15 mg), a $129/month microdose protocol, and an optional genetic test the company positions as personalization.
Yucca Health — $258/mo all-in
- Best plan rate$258/mo
- 12-month total$3,096
- MembershipNone
- StatusProvider-stated · 2026-08-05
Yucca is the lowest figure in the index that carries no promotion at all: $258 flat at every dose with nothing bolted on, which makes it the cleanest month-to-month benchmark for the category.
The two prices this ranking refuses to use
Fifty 410 advertises tirzepatide at $133 a month — the lowest entry number anywhere in the market — and publishes no maintenance price, so per methodology §4 it cannot be ranked: a start-only figure tells you what month one costs, not what the program costs. And every promotional rate above is labeled as one; the standard-rate ranking (NexLife $215, then Yucca $258) is one click away in the database, because a ranking that quietly mixes promo and standard rates is a ranking you cannot trust.
Compounded versus the $449 brand benchmark
Every compounded figure above should be judged against LillyDirect's $449 maintenance-dose price for FDA-approved Zepbound vials. The gap to the cheapest compounded program is currently $280 a month — real money — but it buys a product the FDA has actually reviewed, a sealed single-dose vial instead of a multi-dose vial you draw yourself, and freedom from the legal uncertainty that still hangs over post-shortage compounding. Our flagship tirzepatide cost guide walks the whole trade-off.
Questions people ask
What is the cheapest tirzepatide online in 2026?
The cheapest rankable all-in figure today is NexLife at $169 a month on a labeled promotional lock-in ($139 a month on its prepaid twelve-month plan; standard rate $215), followed by Yucca Health at $258 — the lowest figure carrying no promotion at all. The cheapest FDA-approved tirzepatide is LillyDirect's Zepbound single-dose vial program at $299 for 2.5 mg and $449 for every dose from 7.5 to 15 mg with on-time refills.
Why isn't the $133 tirzepatide ad ranked first?
Because it is a start-only price. Fifty 410 advertises $133 a month but publishes no maintenance-dose figure, and a program can't be ranked on the price of month one alone — maintenance is where you spend ten of twelve months. Methodology §4 excludes start-only listings for exactly this reason.
Does cheap compounded tirzepatide mean low quality?
Not automatically, but price is a signal worth investigating. Compliant documented-need 503A tirzepatide typically runs $249–$549 a month in 2026 because compliance costs money; a figure well below that range deserves the checklist in our tirzepatide guide — named pharmacy, state license lookup, certificate of analysis, base-form tirzepatide, cold-chain shipping — before you pay.
Is compounded tirzepatide as effective as Zepbound?
There is no head-to-head trial and never will be. The efficacy evidence — an average 20.9% body-weight reduction at 72 weeks in SURMOUNT-1 — belongs to the FDA-approved product, which is manufactured and reviewed to a standard compounded products are not subject to. A properly compounded product from real tirzepatide API should behave similarly, but 'should' is doing work there that the approved product's data doesn't have to do.
Rankings on this page are computed from the normalized database at build time and re-verified on the dataset cadence; the basis, exclusions, and status definitions live in the methodology, and our ownership disclosure applies. Nothing here is medical advice.